These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36645571)

  • 1. The dysregulation of plasma miR-497/FGF23 axis, and its association with clinical characteristics and major adverse cardiovascular event in female premature acute coronary syndrome patients.
    Jiang Y; Cai W; Cai G; Wang D; Wu Q
    Ir J Med Sci; 2023 Oct; 192(5):2105-2115. PubMed ID: 36645571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum histone deacetylase 4 longitudinal change for estimating major adverse cardiovascular events in acute coronary syndrome patients receiving percutaneous coronary intervention.
    Xu H; Zhang J; Jia H; Xing F; Cong H
    Ir J Med Sci; 2023 Dec; 192(6):2689-2696. PubMed ID: 36849652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of β2-Microglobulin and Fibroblast Growth Factor 23 with Major Adverse Cardiac Event in Acute Coronary Syndrome Patients with Chronic Kidney Disease.
    Ginanjar E; Alwi I; Lydia A; Immanuel S; Yamin M; Indrajaya T; Harimurti K
    Acta Med Indones; 2021 Jan; 53(1):5-12. PubMed ID: 33818401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-223-5p serves as a diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after PCI.
    Zhang S; Yang G; Chen Y; Liu W
    BMC Cardiovasc Disord; 2024 Aug; 24(1):423. PubMed ID: 39138398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients.
    Zhang W; Chang G; Cao L; Ding G
    BMC Cardiovasc Disord; 2021 Feb; 21(1):74. PubMed ID: 33546604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-497/fibroblast growth factor-23 axis, a predictive indictor for decreased major adverse cardiac and cerebral event risk in end-stage renal disease patients who underwent continuous ambulatory peritoneal dialysis.
    Liu D; Zhou S; Mao H
    J Clin Lab Anal; 2020 Jun; 34(6):e23220. PubMed ID: 32077150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome.
    Kallmeyer A; Pello A; Cánovas E; Aceña Á; González-Casaus ML; Tarín N; Cristóbal C; Gutiérrez-Landaluce C; Huelmos A; Rodríguez-Valer A; González-Lorenzo Ó; Alonso J; López-Bescós L; Egido J; Mahillo I; Lorenzo Ó; Tuñón J
    ESC Heart Fail; 2024 Feb; 11(1):240-250. PubMed ID: 37950429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Exosomal MicroRNA-186-5p Positively Correlates with Lipid Indexes, Coronary Stenosis Degree, and Major Adverse Cardiovascular Events in Coronary Heart Disease.
    Ren L; Liu W; Chen S; Zeng H
    Tohoku J Exp Med; 2024 Feb; 262(2):97-103. PubMed ID: 38057119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implication of homocysteine in premature acute coronary syndrome female patients: Its distribution and association with clinical characteristics and major adverse cardiovascular events risk.
    Zhao Y; Zhang J
    Medicine (Baltimore); 2021 May; 100(18):e25677. PubMed ID: 33950947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of plasma N-acetyl-neuraminic acid level with TIMI risk stratification and clinical outcomes in patients with acute coronary syndrome].
    Li M; Qian S; Yao Z; Min S; Shi X; Kang P; Zhang N; Wang X; Gao D; Gao Q; Zhang H; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Sep; 40(9):1253-1258. PubMed ID: 32990230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
    Mani P; Puri R; Schwartz GG; Nissen SE; Shao M; Kastelein JJP; Menon V; Lincoff AM; Nicholls SJ
    JAMA Cardiol; 2019 Apr; 4(4):314-320. PubMed ID: 30840024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating mir-483-5p as a novel diagnostic biomarker for acute coronary syndrome and its predictive value for the clinical outcome after PCI.
    Zhao Y; Song X; Ma Y; Liu X; Peng Y
    BMC Cardiovasc Disord; 2023 Jul; 23(1):360. PubMed ID: 37464313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome.
    Kawabe M; Sato A; Hoshi T; Sakai S; Hiraya D; Watabe H; Kakefuda Y; Ishibashi M; Abe D; Takeyasu N; Aonuma K
    J Cardiol; 2016 Feb; 67(2):170-6. PubMed ID: 26228000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the prognostic ability of serum uric acid for elderly acute coronary syndrome patients with diabetes mellitus: a prospective cohort study.
    Jiao Y; Wang J; Yang X; Shen M; Xue H; Guo J; Dong W; Chen Y; Xi Q; Fu Z
    J Zhejiang Univ Sci B; 2021 Oct; 22(10):856-865. PubMed ID: 34636188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.
    Bittner VA; Szarek M; Aylward PE; Bhatt DL; Diaz R; Edelberg JM; Fras Z; Goodman SG; Halvorsen S; Hanotin C; Harrington RA; Jukema JW; Loizeau V; Moriarty PM; Moryusef A; Pordy R; Roe MT; Sinnaeve P; Tsimikas S; Vogel R; White HD; Zahger D; Zeiher AM; Steg PG; Schwartz GG;
    J Am Coll Cardiol; 2020 Jan; 75(2):133-144. PubMed ID: 31948641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine as a potential predictive factor for high major adverse cardiovascular events risk in female patients with premature acute coronary syndrome.
    Wei M; Wang L; Liu YS; Zheng MQ; Ma FF; Qi YC; Liu G
    Medicine (Baltimore); 2019 Nov; 98(47):e18019. PubMed ID: 31764817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-146a rs2910164 (G/C) polymorphism is associated with the development and prognosis of acute coronary syndromes: an observational study including case control and validation cohort.
    Qiao XR; Zheng T; Xie Y; Yao X; Yuan Z; Wu Y; Zhou D; Chen T
    J Transl Med; 2023 May; 21(1):325. PubMed ID: 37189131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA MALAT1 and its target microRNA-125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease.
    Lv F; Liu L; Feng Q; Yang X
    J Clin Lab Anal; 2021 Apr; 35(4):e23593. PubMed ID: 33660877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between metabolites of arachidonic acid and prognosis in patients with acute coronary syndrome.
    Zu L; Guo G; Zhou B; Gao W
    Thromb Res; 2016 Aug; 144():192-201. PubMed ID: 27393924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.